Nateglinide
Who holds supplier records for Nateglinide? 6 organisations hold a current record for Nateglinide: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Nateglinide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nateglinide
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nateglinide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 21484, 28934 · latest filing Jan 2015
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 17847 · latest filing Nov 2004
- SYNTHIMED LABS PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 20231 · latest filing Jan 2007
- TAPI NL BVNetherlandsActive DMF 17910 · latest filing Dec 2004
- USV PRIVATE LTDIndia Company GMP cert on recordActive DMF 26882 · latest filing Mar 2013
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 37501 · latest filing Sept 2022
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (1)
Certificates of Suitability on the EDQM register for Nateglinide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 2 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2015-134 - Rev 01 Nateglinide, Form H | Nov 2024 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Nateglinide are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- India · Inactive DMF 17906 · filed Dec 2004
- Japan · Inactive DMF 11155 · filed Oct 1994
Overview
Nateglinide is an oral antidiabetic agent that stimulates insulin secretion by binding to sulfonylurea receptors on pancreatic beta cells. It is used to improve glycemic control in adults with type 2 diabetes mellitus.
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Glinide
- Mechanism of action
- Potassium Channel Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nateglinide?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Nateglinide: Unichem Laboratories Ltd. (India), Dr. Reddy's Laboratories Ltd. (India), SYNTHIMED LABS PRIVATE LIMITED (India), TAPI NL BV (Netherlands), USV PRIVATE LTD (India) and Zydus Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nateglinide Drug Master Files are active?
Unichem Laboratories Ltd. (DMF 21484, 28934), Dr. Reddy's Laboratories Ltd. (DMF 17847), SYNTHIMED LABS PRIVATE LIMITED (DMF 20231), TAPI NL BV (DMF 17910), USV PRIVATE LTD (DMF 26882) and Zydus Lifesciences Limited (DMF 37501). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nateglinide records mean?
2 organisations have only inactive Type II DMFs for Nateglinide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Nateglinide have a European Certificate of Suitability?
Yes. 1 organisation holds a valid CEP for Nateglinide on the EDQM register, including UNICHEM LABORATORIES LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Nateglinide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nateglinide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.